News by topic

Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Clinical trials news

Show

From To
PrEP
UK: Are you willing to take part in research that aims to reduce your risk of HIV?

PROUD is a two-year study to recruit gay and bisexual men across England, who will be placed at random into one of two groups. One group will use PrEP from the start of the study, and the other group will receive PrEP after 12 months.

Published
16 May 2013
From
PROUD study, UK Medical Research Council
Clinical trials
Health NGO pushes for more transparency in clinical trials

The European Commission's proposed revision on the Clinical Trials Directive is an important step forward, but does not go far enough, says the Cochrane Collaboration, a healthcare NGO which advocates more transparency in clinical trials.

Published
02 May 2013
From
EurActiv.com
Clinical trials
Clinical Trials Regulation: Protect public health: Choose transparency!

EATG joined 10 European and International Organisations representing researchers, doctors, scientists, patients and other civil society actors in a call for the inclusion of strong transparency provisions in the Clinical Trials Regulation that is under discussion at the European Parliament and Council.

Published
12 April 2013
From
EATG
Clinical trials
EATG Position Paper on the Clinical Trials Regulation proposed by the European Commission

EATG has adopted a Position Paper on the EU Clinical Trials Regulation, which is under discussion within the Council of the EU and European Parliament following the European Commission’s proposal.

Published
11 April 2013
From
EATG
Clinical trials
Big pharma, big data

From the beginning of next year, the European Medicines Agency will release all information about clinical studies submitted to it by organisations seeking authorisation for new treatments. As this deadline approaches, heated parliamentary and legal debates are raging to determine how far this new culture of open access should go.

Published
05 April 2013
From
Financial Times
Side-effects
EU new drug approval studies "have too few patients to evaluate safety"

For medicines intended for chronic use, the number of patients studied before regulatory approval in the European Union (EU) is insufficient to properly evaluate safety and long-term efficacy, and this points to a need for new EU legislation, say researchers writing in this week's PLOS Medicine.

Published
22 March 2013
From
Pharma Times
Clinical trials
Testing HIV Prevention Tools: Other Ways Up the Alley

We need to design prevention trials that ask, “Is this test product better than nothing?” rather than, “Is this test product better than the best available prevention combination we have?”

Published
15 March 2013
From
Poz
Clinical trials
Panel Urges NIH to Reduce HIV, Hep C Research on Primates

The National Institutes of Health (NIH) should reduce its use of chimpanzees for medical research, according to an NIH-commissioned working group.

Published
06 February 2013
From
Poz magazine news
Prevention of mother-to-child transmission
HIV trial under scrutiny

A potential breakthrough in the quest to prevent HIV and AIDS has collided with sensitivities about testing expensive drugs in poor parts of the world.

Published
17 January 2013
From
Nature.com
Clinical trials
Industry Funding Changes Study Results, Research Shows

Drugs and medical devices tend to appear more beneficial in scientific papers if they were manufactured by the company that sponsored the study, showing that who pays for the clinical trial has a direct impact on the reported outcome, according to a new analysis by researchers at UCSF and the Cochrane Collaboration.

Published
20 December 2012
From
University of California press release
← First12345...8Next →

Filter by country